Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli

GLIA

Volumn 55, Issue 3, 2007, Pages 239-252

  Carpentier, Pamela A ^a,c   Williams, Bryan R ^b   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MONASH UNIVERSITY   (Australia)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Chemokines; CNS; Cytokines; dsRNA; Innate immune; Multiple sclerosis; TMEV

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE R; TOLL LIKE RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOTOXICITY; DEMYELINATION; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; INNATE IMMUNITY; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PICORNAVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; VIRUS ENCEPHALITIS; VIRUS INFECTION;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CHEMOKINES; CYTOKINES; EIF-2 KINASE; ENZYME ACTIVATION; GLIOSIS; IMMUNOLOGIC SURVEILLANCE; INTERFERONS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; POLY I-C; THEILOVIRUS; TOLL-LIKE RECEPTOR 3;

EID: 33846881124     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20450     Document Type: Article

References (69)

1. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA, activation of NF-κB by toll-like receptor 3. Nature 413:732-738.
2. Auch CJ, Saha RN, Sheikh FG, Liu X, Jacobs BL, Pahan K. 2004. Role of protein kinase R in double-stranded RNA-induced expression of nitric oxide synthase in human astroglia. FEBS Lett 563:223-228.
3. Bailey SL, Carpentier PA, McMahon EJ, Begolka WS, Miller SD. 2006. Innate and adaptive immune responses of the central nervous system. Crit Rev Immunol 26:149-188.
4. Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, Archer DR, Barber GN. 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13:129-141.
5. Balashov KE, Rottman JB, Weiner HL, Hancock WW. 1999. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 96:6873-6878.
6. Brown AS, Susser ES. 2002. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev 8:51-57.
7. Bsibsi M, Ravid R, Gveric D, van Noort JM. 2002. Broad expression of toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61:1013-1021.
8. Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD. 2005. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49:360-374.
9. Chakrabarty A, Danley MM, LeVine SM. 2004. Immunohistochemical localization of phosphorylated protein kinase R, phosphorylated eukaryotic initiation factor-2 α in the central nervous system of SJL mice with experimental allergic encephalomyelitis. J Neurosci Res 76:822-833.
10. Chamorro M, Aubert C, Brahic M. 1986. Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection. J Virol 57:992-997.
11. Chang RC, Wong AK, Ng HK, Hugon J. 2002. Phosphorylation of eukaryotic initiation factor-2α (eIF2α) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport 13:2429-2432.
12. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW. 2003. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2. J Virol 77:4588-4596.
13. Croxford JL, Olson JK, Miller SD. 2002. Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus induced demyelinating disease model of multiple sclerosis. Autoimmun Rev 1:251-260.
14. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e S. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529-1531.
15. Doyle S, Vaidya S, O'Connell R, Dadgostar H, Dempsey P, Wu T, Rao G, Sun R, Haberland M, Modlin R, Cheng G. 2002. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17:251-263.
16. Farina C, Krumbholz M, Giese T, Hartmann G, Aloisi F, Meinl E. 2005. Preferential expression and function of toll-like receptor 3 in human astrocytes. J Neuroimmunol 159:12-19.
17. Fiette L, Aubert C, Muller U, Huang S, Aguet M, Brahic M, Bureau JF. 1995. Theiler's virus infection of 129Sv mice that lack the interferon α/β or interferon γ receptors. J Exp Med 181:2069-2076.
18. Gilden DH. 2005. Infectious causes of multiple sclerosis. Lancet Neurol 4:195-202.
19. Griffin DE. 2003. Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol 3:493-502.
20. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M. 2005. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA, influenza A virus. J Biol Chem 280:5571-5580.
21. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA. 2001. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 75:10730-10737.
22. Hedreen JC, Folstein SE. 1995. Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 54:105-120.
23. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526-1529.
24. Hoebe K, Janssen EM, Kim SO, Alexopoulou L, Flavell RA, Han J, Beutler B. 2003. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 4:1223-1229.
25. Hu Y, Conway TW. 1993. 2-Aminopurine inhibits the double-stranded RNA-dependent protein kinase both in vitro and in vivo. J Interferon Res 13:323-328.
26. Jefferies CA, Fitzgerald KA. 2005. Interferon gene regulation: Not all roads lead to tolls. Trends Mol Med 11:403-411.
27. Kurtzke JF. 1993. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 6:382-427.
28. Levin DH, Petryshyn R, London IM. 1980. Characterization of double-stranded-RNA-activated kinase that phosphorylates α subunit of eukaryotic initiation factor 2 (eIF-2 α) in reticulocyte lysates. Proc Natl Acad Sci USA 77:832-836.
29. Lipton HL, Twaddle G, Jelachich ML. 1995. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol 69:2525-2533.
30. MacGowan DJ, Scelsa SN, Waldron M. 2001. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 57:1094-1097.
31. Maimone D, Guazzi GC, Annunziata P. 1997. IL-6 detection in multiple sclerosis brain. J Neurol Sci 146:59-65.
32. Marques JT, Williams BR. 2005. Activation of the mammalian immune system by siRNAs. Nat Biotechnol 23:1399-1405.
33. Matsumoto M, Funami K, Oshiumi H, Seya T. 2004. Toll-like receptor 3: A link between toll-like receptor, interferon and viruses. Microbiol Immunol 48:147-154.
34. Matsumoto M, Funami K, Tanabe M, Oshiumi H, Shingai M, Seto Y, Yamamoto A, Seya T. 2003. Subcellular localization of toll-like receptor 3 in human dendritic cells. J Immunol 171:3154-3162.
35. McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 11:335-339.
36. Melchjorsen J, Pedersen FS, Mogensen SC, Paludan SR. 2002. Herpes simplex virus selectively induces expression of the CC chemokine RANTES/CCL5 in macrophages through a mechanism dependent on PKR, ICP0. J Virol 76:2780-2788.
37. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 3:1133-1136.
38. Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C. 2002. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 202:13-23.
39. Olson JK, Miller SD. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173:3916-3924.
40. Ong CL, Thorpe JC, Gorry PR, Bannwarth S, Jaworowski A, Howard JL, Chung S, Campbell S, Christensen HS, Clerzius G, et al. 2005. Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response. J Virol 79:12763-12772.
41. Palma JP, Kim BS. 2001. Induction of selected chemokines in glial cells infected with Theiler's virus. J Neuroimmunol 117:166-170.
42. Palma JP, Kim BS. 2004. The scope and activation mechanisms of chemokine gene expression in primary astrocytes following infection with Theiler's virus. J Neuroimmunol 149:121-129.
43. Palma JP, Kwon D, Clipstone NA, Kim BS. 2003. Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-κB activation: Potential role for the initiation of demyelinating disease. J Virol 77:6322-6331.
44. Park C, Lee S, Cho IH, Lee HK, Kim D, Choi SY, Oh SB, Park K, Kim JS, Lee SJ. 2006. TLR3-mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: Differential signaling mechanisms of TLR3-induced IP-10 and IL-8 gene expression. Glia 53:248-256.
45. Peel AL, Bredesen DE. 2003. Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice. Neurobiol Dis 14:52-62.
46. Peel AL, Rao RV, Cottrell BA, Hayden MR, Ellerby LM, Bredesen DE. 2001. Double-stranded RNA-dependent protein kinase PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue. Hum Mol Genet 10:1531-1538.
47. Samuel CE. 2001. Antiviral actions of interferons. Clin Microbiol Rev 14:778-809.
48. Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA, Achim CL. 1998. Chemokines and receptors in HIV encephalitis. AIDS 12:1021-1026.
49. Sato M, Hata N, Asagiri M, Nakaya T, Taniguchi T, Tanaka N. 1998a. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 441:106-110.
50. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, et al. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 13:539-548.
51. Sato M, Tanaka N, Hata N, Oda E, Taniguchi T. 1998b. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-β gene. FEBS Lett 425:112-116.
52. Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, Takeda K, Akira S. 2003. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κ B, IFN-regulatory factor-3, in the toll-like receptor signaling. J Immunol 171:4304-4310.
53. Schroder M, Bowie AG. 2005. TLR3 in antiviral immunity: Key player or bystander? Trends Immunol 26:462-468.
54. Scumpia PO, Kelly KM, Reeves WH, Stevens BR. 2005. Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes. Glia 52:153-162.
55. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. 1998. Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 84:238-249.
56. Smith KJ, Kapoor R, Felts PA. 1999. Demyelination: The role of reactive oxygen and nitrogen species. Brain Pathol 9:69-92.
57. So EY, Kang MH, Kim BS. 2006. Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the toll-like receptor 3. Glia 53:858-867.
58. Sun N, Grzybicki D, Castro RF, Murphy S, Perlman S. 1995. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213:482-493.
59. Trottier M, Schlitt BP, Lipton HL. 2002. Enhanced detection of Theiler's virus RNA copy equivalents in the mouse central nervous system by real-time RT-PCR. J Virol Methods 103:89-99.
60. Vanderlugt CL, Miller SD. 2002. Epitope spreading in immune-mediated diseases: Implications for immunotherapy. Nat Rev Immunol 2:85-95.
61. Wang J, Asensio VC, Campbell IL. 2002. Cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice. Curr Top Microbiol Immunol 265:23-48.
62. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10:1366-1373.
63. Wekerle H. 1991. Immunopathogenesis of multiple sclerosis. Acta Neurologica 13:197-204.
64. Whitton JL, Cornell CT, Feuer R. 2005. Host and virus determinants of picornavirus pathogenesis and tropism. Nat Rev Microbiol 3:765-776.
65. Williams BR. 1999. PKR; a sentinel kinase for cellular stress. Oncogene 18:6112-6120.
66. Yang YL, Reis LF, Pavlovic J, Aguzzi A, Schafer R, Kumar A, Williams BR, Aguet M, Weissmann C. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J 14:6095-6106.
67. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730-737.
68. Zamanian-Daryoush M, Mogensen TH, DiDonato JA, Williams BR. 2000. NF-κB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-κB-inducing kinase and IκB kinase. Mol Cell Biol 20:1278-1290.
69. Zheng L, Calenoff MA, Dal Canto MC. 2001. Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination. J Neuroimmunol 118:256-267.